References
- Fauci AS, Lane HC. Human Immunodeficiency Virus Disease: AIDS and related disorders. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al, editors. Harrison‟s principles of internal medicine: Infections due to human immunodeficiency virus and other human retroviruses. 17th ed. Vol1. New York: McGraw Hill; 2008.p.1137-8.
- Kripke C. Antiretroviral prophylaxis for occupational exposure to HIV. Am Fam Physician 2007; 76:375 - 6; PMID: 17708137
- Smith DK, Grohskopf LA, Black RJ, Auerbach JD, Veronese F, Struble KA, Cheever L, Johnson M, Paxton LA, Onorato IM, et al, U.S. Department of Health and Human Services. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep 2005; 54:RR-2 1 - 20; PMID: 15660015
- Dosekun O, Fox J. An overview of the relative risks of different sexual behaviours on HIV transmission. Curr Opin HIV AIDS 2010; 5:291 - 7; http://dx.doi.org/10.1097/COH.0b013e32833a88a3; PMID: 20543603
- AIDS Annual report 2012-13. National Aids Control Organization. India. Available from:http://www.nacoonline.org/upload/Publication/Annual%20Report/Annual%20report%202012-13_English.pdf)
- Das S, Mukhopadhyay A, Ray T. Economic Cost of HIV and AIDS in India. 2009. Available from: http://www.isid.ac.in/~tridip/Research/DasMukhopadhyay&Ray-BookChapter-2009.pdf
- Koff WC, Russell ND, Walport M, Feinberg MB, Shiver JW, Karim SA, Walker BD, McGlynn MG, Nweneka CV, Nabel GJ. Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines. Vaccine 2013; 31:Suppl 2 B204 - 8; http://dx.doi.org/10.1016/j.vaccine.2012.10.115; PMID: 23598483
- Cohen J. Shooting blanks. “Science” writer Jon Cohen speaks of how the search for an HIV vaccine has strayed. Interview by Bob Roehr. IAPAC Mon 2001; 7:268 - 70; PMID: 11708271
- Hulskotte EG, Geretti AM, Osterhaus AD. Towards an HIV-1 vaccine: lessons from studies in macaque models. Vaccine 1998; 16:904 - 15; http://dx.doi.org/10.1016/S0264-410X(97)00292-2; PMID: 9682336
- Joy AK, Dale CJ, Kent SJ. Can HIV infection be prevented with a vaccine?. Drugs R D 1999; 1:431 - 40; http://dx.doi.org/10.2165/00126839-199901060-00001; PMID: 10566076
- Amara RR, Villinger F, Altman JD, Lydy SL, O’Neil SP, Staprans SI, Montefiori DC, Xu Y, Herndon JG, Wyatt LS, et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001; 292:69 - 74; http://dx.doi.org/10.1126/science.1058915; PMID: 11393868
- Pu R, Tellier MC, Yamamoto JK. Mechanism(s) of FIV vaccine protection. Leukemia 1997; 11:Suppl 3 98 - 101; PMID: 9209311
- Rowland-Jones SL, McMichael A. Immune responses in HIV-exposed seronegatives: have they repelled the virus?. Curr Opin Immunol 1995; 7:448 - 55; http://dx.doi.org/10.1016/0952-7915(95)80087-5; PMID: 7495507
- World Health Organization. Initiative for Vaccine Research (IVR), HIV vaccine research and development. Geneva:WHO;2013. Available from: http://www.who.int/vaccine_research/development/hiv_vaccdev/en/index.html
- World Health Organization. HIV/AIDS New global strategy on HIV set to prevent millions of infections, deaths Media Centre. Geneva:WHO;2013. Available from: www.who.int/hiv/mediacentre/feature_story/hiv_strategy/en/index.html